Overexpression of bcl-2 enhances LIGHT- and interferon-gamma -mediated apoptosis in Hep3BT2 cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10993881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TAJ, a Novel Member of the Tumor Necrosis Factor Receptor Family, Activates the c-Jun N-terminal Kinase Pathway and Mediates Caspase-independent Cell Death*

  2000cited by this paper
• Bcl-xL Prevents the Initial Decrease in Mitochondrial Membrane Potential and Subsequent Reactive Oxygen Species Production during Tumor Necrosis Factor Alpha-Induced Apoptosis

  2000cited by this paper
• Death by numbers

  2000cited by this paper
• Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

  2000cited by this paper
• A Predominant Apoptotic Death Pathway of Neuronal PC12 Cells Induced by Activated Microglia Is Displaced by A Non-apoptotic Death Pathway Following Blockage of Caspase-3-dependent Cascade*

  1999cited by this paper
• NH2-terminal BH4 Domain of Bcl-2 Is Functional for Heterodimerization with Bax and Inhibition of Apoptosis*

  1999cited by this paper
• TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells

  1999cited by this paper
• Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase*

  1999cited by this paper
• BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

  1999cited by this paper
• A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis*

  1999cited by this paper
• Molecular characterization of mitochondrial apoptosis-inducing factor

  1999cited by this paper
• Reactive oxygen species regulate activation-induced T cell apoptosis.

  1999cited by this paper
• Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells*

  1999cited by this paper
• TALL‐1 is a novel member of the TNF family that is down‐regulated by mitogens

  1999cited by this paper
• VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo

  1999cited by this paper
• BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.

  1999cited by this paper
• Caspase-3-dependent Cleavage of Bcl-2 Promotes Release of Cytochrome c *

  1999cited by this paper
• Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.

  1999cited by this paper
• Cell death in development.

  1999cited by this paper
• Identification of a Novel Activation-inducible Protein of the Tumor Necrosis Factor Receptor Superfamily and Its Ligand*

  1999cited by this paper
• C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation.

  1999cited by this paper
• Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells

  1999cited by this paper
• Alphaviruses induce apoptosis in Bcl‐2‐overexpressing cells: evidence for a caspase‐mediated, proteolytic inactivation of Bcl‐2

  1998cited by this paper
• Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1.

  1998cited by this paper
• Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by Bcl-2

  1998cited by this paper
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis*

  1998cited by this paper
• Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

  1998cited by this paper
• Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases

  1998cited by this paper
• Apoptotic signal of Fas is not mediated by ceramide.

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• TNF-alpha activates at least two apoptotic signaling cascades.

  1998cited by this paper
• Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene.

  1998cited by this paper
• APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth

  1998cited by this paper
• Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c

  1998cited by this paper
• LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.

  1998cited by this paper
• Bcl-2 Prevents Caspase-independent Cell Death*

  1998cited by this paper
• The Overexpression of Bax Produces Cell Death upon Induction of the Mitochondrial Permeability Transition*

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins

  1998cited by this paper
• Two CD95 (APO‐1/Fas) signaling pathways

  1998cited by this paper
• Bcl-2 Blocks Apoptotic Signal of Transforming Growth Factor-β in Human Hepatoma Cells

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• The conserved N‐terminal BH4 domain of Bcl‐2 homologues is essential for inhibition of apoptosis and interaction with CED‐4

  1998cited by this paper
• Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice.

  1997cited by this paper
• TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor

  1997cited by this paper
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation*

  1997cited by this paper
• Conversion of Bcl-2 to a Bax-like death effector by caspases.

  1997cited by this paper
• Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.

  1997cited by this paper
• ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5*

  1997cited by this paper
• Carboxyfullerenes as neuroprotective agents.

  1997cited by this paper
• Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1*

  1997cited by this paper
• Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils.

  1997cited by this paper
• TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis*

  1997cited by this paper
• The proto-oncogene Bcl-2 and its role in regulating apoptosis

  1997cited by this paper
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*

  1997cited by this paper
• BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases.

  1996cited by this paper
• Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis

  1996cited by this paper
• Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.

  1996cited by this paper
• Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1*

  1996cited by this paper
• Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells.

  1996cited by this paper
• Bcl-2 interrupts the ceramide-mediated pathway of cell death.

  1996cited by this paper
• Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

  1996cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity.

  1995cited by this paper
• The TNF ligand superfamily and its relevance for human diseases.

  1995cited by this paper
• Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA

  1995cited by this paper
• Cell‐free reconstitution of Fas‐, UV radiation‐ and ceramide‐induced apoptosis.

  1995cited by this paper
• Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria.

  1995cited by this paper
• A lymphotoxin-beta-specific receptor.

  1994cited by this paper
• Inhibition of activation‐induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis

  1994cited by this paper
• Bcl-2 functions in an antioxidant pathway to prevent apoptosis.

  1993cited by this paper
• Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species.

  1993cited by this paper
• The pathophysiology of tumor necrosis factors.

  1992cited by this paper
• Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

  1985cited by this paper

• Integrated experimental and computational approaches to analyze TNF superfamily ligand-receptor interactions.

  2026cites this paper
• Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope

  2022cites this paper
• LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.

  2020cites this paper
• Costimulation of Murine Osteoblasts with Interferon-γ and Tumor Necrosis Factor-α Induces Apoptosis through Downregulation of Bcl-2 and Release of Cytochrome c from Mitochondria

  2018cites this paper
• Context-dependent roles for lymphotoxin-β receptor signaling in cancer development.

  2016cites this paper
• Lentivirus-mediated LIGHT overexpression inhibits human colorectal carcinoma cell growth in vitro and in vivo

  2013cites this paper
• LIGHT (TNFSF14/CD258) Is a Decisive Factor for Recovery from Experimental Autoimmune Encephalomyelitis

  2013cites this paper
• Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation.

  2013cites this paper
• Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis

  2013cites this paper
• Autoimmune Encephalomyelitis Factor for Recovery from Experimental LIGHT (TNFSF14/CD258) Is a Decisive

  2013cites this paper
• The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.

  2012cites this paper
• Synergistic effect of IFN-γ gene on LIGHT-induced apoptosis in HepG2 cells via down regulation of Bcl-2.

  2011cites this paper
• IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1

  2011cites this paper
• Circulating lymphotoxin β receptor and atherosclerosis: observations from the Dallas Heart Study.

  2010cites this paper
• TNF family members and malaria: old observations, new insights and future directions.

  2010cites this paper
• Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting.

  2009cites this paper
• Caspase-3 gene transfected with LIGHT gene: can it be used for therapy of human hepatocellular carcinoma?

  2008cites this paper
• Chronic viral hepatitis and iron affect the plasma levels of LIGHT--a new member of the TNF superfamily in uraemic haemodialyzed patients.

  2007cites this paper
• The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.

  2007cites this paper
• Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.

  2007cites this paper
• Survival Factor Withdrawal-induced Apoptosis of TF-1 Cells Involves a TRB2-Mcl-1 Axis-dependent Pathway*

  2007cites this paper
• Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis.

  2006cites this paper
• Aberrant Expression of Light and its Associated Receptors in Systemic Lupus Erythematosus and Coeliac Disease

  2006cites this paper
• Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy.

  2006cites this paper
• Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3.

  2006cites this paper
• Experimental therapy using interferon-gamma and anti-Fas antibody against oral malignant melanoma cells

  2005cites this paper
• N‐methyl‐D‐aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal‐regulated kinase pathway

  2005cites this paper
• Induction of apoptosis and cytokine production in the Jurkat human T cells by deoxynivalenol: role of mitogen-activated protein kinases and comparison to other 8-ketotrichothecenes.

  2005cites this paper
• Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.

  2005cites this paper
• Induction of Apoptosis in Glioma Cells by Molecules Released from Activated Macrophages

  2004cites this paper
• Mechanism of LIGHT/interferon‐γ‐induced cell death in HT‐29 cells

  2004cites this paper
• Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.

  2004cites this paper
• Sensitization of interferon-γ induced apoptosis in human osteosarcoma cells by extracellular S100A4

  2004cites this paper
• LIGHT sensitizes IFNγ–mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways

  2004cites this paper
• Mechanism of LIGHT/interferon-gamma-induced cell death in HT-29 cells.

  2004cites this paper
• Soluble receptor (DcR3) and cellular inhibitor of apoptosis-2 (cIAP-2) protect human cytotrophoblast cells against LIGHT-mediated apoptosis.

  2004cites this paper
• LIGHT sensitizes IFNgamma-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members.

  2003cites this paper
• The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death.

  2003cites this paper
• Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent.

  2003cites this paper
• Modulation of Dendritic Cell Differentiation and Maturation by Decoy Receptor 31

  2002cites this paper
• Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis

  2002cites this paper
• Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteins

  2002cites this paper
• LIGHT, a Member of the Tumor Necrosis Factor Ligand Superfamily, Prevents Tumor Necrosis Factor-α-mediated Human Primary Hepatocyte Apoptosis, but Not Fas-mediated Apoptosis*

  2002cites this paper
• LIGHT, a new member of the TNF superfamily.

  2002cites this paper
• Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes.

  2002cites this paper
• Pro-apoptotic Cleavage Products of Bcl-xL Form Cytochrome c-conducting Pores in Pure Lipid Membranes*

  2001cites this paper